Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to MYELOMA

The New England Journal of Medicine

Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma

Hematology/Oncology June 10th 2024

MD Newsline

Real-World Outcomes in Newly Diagnosed Multiple Myeloma Based on iFISH

Hematology/Oncology May 20th 2024

Annals of Internal Medicine

Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons with Monoclonal Gammopathy of Undetermined Significance

Hematology/Oncology April 8th 2024

Oncology Learning Network

FDA Approves Biweekly Dosing of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma

Hematology/Oncology March 4th 2024

The New England Journal of Medicine

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Hematology/Oncology January 2nd 2024

Hematology Advisor

Palliative Radiotherapy Linked to Pain Response in Multiple Myeloma

Hematology November 6th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form